Onconetix ONCO
NASDAQ ONCO
$0.73 -0.01 (-1.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Onconetix (ONCO) Gains from Sales and Divestitures (2025)

Updated

Onconetix (ONCO) recorded Gains from Sales and Divestitures of -$250.00 in Q4 2025.

Analysis

Onconetix (ONCO) Gains from Sales and Divestitures (2025) Analysis & Trends

For FY2025, Onconetix reported Gains from Sales and Divestitures of -$17,283.

  • Across earlier years, Gains from Sales and Divestitures came in at -$267,019 in FY2023 and -$1,199 in FY2021.
  • Per Business Quant, the preceding three quarters came in at -$551.00 (Q3 2025), -$14,010 (Q2 2025) and -$2,472 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Onconetix 1.64 Mn -14.08 Mn 4,303.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -250.00
Sep 30, 2025 -551.00
Jun 30, 2025 -14,010.00
Mar 31, 2025 -2,472.00
API Access

Onconetix Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ONCO&period=max&api_key=YOUR_API_KEY